191420 — Tego Science Share Price
Last trade - 00:00- KR₩179bn
- KR₩159bn
- KR₩8bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.84 | ||
| Price to Tang. Book | 4.01 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 22.97 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -4.99% | ||
| Return on Equity | -4.89% | ||
| Operating Margin | -29.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 6,346.02 | 8,789.1 | 8,299.61 | 7,678.39 | 7,772.41 | n/a | n/a | -0.2% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -41.67 | -75.72 | +90.78 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tego Science,Inc. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of wound-healing skin cell therapy products. The Company’s products mainly consist of cell therapy products, and laboratory cultured skin models.
Directors
- Se Hwa Jeon PRE (47)
- Byeong Hae Noh OTH (76)
- Jae Wuk Jeon DRC (50)
- Hyeon Yim DRC (41)
- Yang Gyun Kim NID (47)
- Yin Hyeong Lee NID (57)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 20th, 2001
- Public Since
- November 6th, 2014
- No. of Shareholders
- 8,626
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 8,006,566
- Address
- 93, Magokjungang 8-ro, Gangseo-gu, SEOUL, 07794
- Web
- http://www.tegoscience.com/
- Phone
- +82 28182900
- Auditors
- Daejoo Accounting Corp.
Upcoming Events for 191420
Similar to 191420
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Ahn-Gook Pharmaceutical Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:21 UTC, shares in Tego Science are trading at KR₩22,300. This share price information is delayed by 15 minutes.
Shares in Tego Science last closed at KR₩22,300 and the price had moved by +57.47% over the past 365 days. In terms of relative price strength the Tego Science share price has outperformed the FTSE Developed Asia Pacific Index by +58.55% over the past year.
There is no consensus recommendation for this security.
Tego Science does not currently pay a dividend.
Tego Science does not currently pay a dividend.
Tego Science does not currently pay a dividend.
To buy shares in Tego Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩22,300, shares in Tego Science had a market capitalisation of KR₩179bn.
Here are the trading details for Tego Science:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 191420
Based on an overall assessment of its quality, value and momentum Tego Science is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tego Science. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +135.42%.
As of the last closing price of KR₩22,300, shares in Tego Science were trading +84.52% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tego Science PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩22,300.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tego Science's management team is headed by:
- Se Hwa Jeon - PRE
- Byeong Hae Noh - OTH
- Jae Wuk Jeon - DRC
- Hyeon Yim - DRC
- Yang Gyun Kim - NID
- Yin Hyeong Lee - NID